Received Jun 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | L5229 | IM / RA |
It was reported through our pharmacy corporate office during an audit that patient had received Boostrix on 02/26/25 and should not have received another dose on 6/12/25. Patient was called, and she reported no side effects.
N/a
N/a
N/a
n/a
n/a